ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Ag boosts deal values

by Marc S. Reisch
August 1, 2016 | APPEARED IN VOLUME 94, ISSUE 31

The value of chemical merger and acquisition offers reached $67.1 billion in the second quarter of this year, mostly because of activity in agricultural chemicals. Deal values in the quarter were almost seven times as high as those in the year-earlier quarter, according to a recent report from consulting firm PricewaterhouseCoopers. Most of the increase was driven by one $55.2 billion megadeal—Bayer’s proposed acquisition of Monsanto—which, along with a subsequent offer in July, was rejected. Because of agricultural chemical deals, aggregate values in each of the past three quarters have exceeded $60 billion, a figure unprecedented since the Great Recession, PwC says. Those deals include Dow Chemical’s merger with DuPont and ChemChina’s planned purchase of Syngenta. Shareholders have already approved the Dow-DuPont combination. If one or both of the other deals move forward, they will likely trigger a round of divestitures and provide opportunities for players now sitting on the sidelines, PwC points out.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment